Senior insider sale
Chief Executive Officer at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$4.21M
154.86K shares
COLOMA JASON V plans to sell 154.86K shares of MAZE THERAPEUTICS, INC. valued at approximately $4.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Restricted Stock Unit Vesting Compensation | 23.50K | — |
| Total | 23.50K | ||
Completed
Units to sell
2.59K
Market value
$68.2K
Units to sell
31.91K
Market value
$838.8K
Units to sell
2.59K
Market value
$69.3K
Units to sell
31.91K
Market value
$853.0K
Units to sell
31.91K
Market value
$956.5K
Units to sell
2.59K
Market value
$77.7K
Units to sell
23.86K
Market value
$621.7K
Units to sell
1.95K
Market value
$50.8K
Units to sell
2.04K
Market value
$53.0K
Planned — Approximate Date
Units to sell
23.50K
Market value
$623.4K
Units
154.86K
Value
$4.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 2.59K | $68.2K | — | Completed |
9/1/2026 | 31.91K | $838.8K | — | Completed |
8/3/2026 | 2.59K | $69.3K | — | Completed |
8/3/2026 | 31.91K | $853.0K | — | Completed |
7/1/2026 | 31.91K | $956.5K | — | Completed |
7/1/2026 | 2.59K | $77.7K | — | Completed |
6/23/2026 | 23.86K | $621.7K | — | Completed |
6/22/2026 | 1.95K | $50.8K | — | Completed |
6/22/2026 | 2.04K | $53.0K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 23.50K | $623.4K | NASDAQ | Planned |
| Total | 154.86K | $4.21M | ||